Symbols / NBY
NBY Chart
About
NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 43.11M |
| Enterprise Value | 44.56M | Income | -6.99M | Sales | 10.30M |
| Book/sh | -2.23 | Cash/sh | 0.09 | Dividend Yield | — |
| Payout | 0.00% | Employees | 13 | IPO | — |
| P/E | 0.06 | Forward P/E | -2.01 | PEG | — |
| P/S | 4.18 | P/B | -0.74 | P/C | — |
| EV/EBITDA | -8.73 | EV/Sales | 4.33 | Quick Ratio | 1.89 |
| Current Ratio | 2.00 | Debt/Eq | 59.36 | LT Debt/Eq | — |
| EPS (ttm) | 25.80 | EPS next Y | -0.82 | EPS Growth | — |
| Revenue Growth | -78.70% | Earnings | 2025-08-12 15:00 | ROA | -86.98% |
| ROE | -5.16% | ROIC | — | Gross Margin | 63.32% |
| Oper. Margin | -224.38% | Profit Margin | 31.48% | Shs Outstand | 26.12M |
| Shs Float | 2.05M | Short Float | 2.16% | Short Ratio | 1.19 |
| Short Interest | — | 52W High | 99.75 | 52W Low | 1.55 |
| Beta | 0.01 | Avg Volume | 428.67K | Volume | 1.09M |
| Target Price | — | Recom | None | Prev Close | $2.10 |
| Price | $1.65 | Change | -21.43% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.65
Latest analyst target
3. DCF / Fair value
$-1.82
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.65
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-11-11 | main | Ascendiant Capital | Buy → Buy | $1 |
| 2023-08-11 | main | Ladenburg Thalmann | Buy → Buy | $4 |
News
RSS: Latest NBY news- Auditor change as NovaBay (NBY) seeks approval to dissolve - Stock Titan Wed, 28 Jan 2026 08
- NovaBay Pharma Implements Reverse Stock Split of Shares - TipRanks Fri, 20 Feb 2026 21
- NovaBay Pharmaceuticals stock falls after $100 million ATM offering - Investing.com ue, 20 Jan 2026 08
- NovaBay falls on deal for $100M stock (update) (NBY:NYSE) - Seeking Alpha ue, 20 Jan 2026 08
- Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales - simplywall.st ue, 13 Jan 2026 08
- NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar - TechStock² Mon, 12 Jan 2026 08
- NBY Stock Jumps Amid Market Anticipation and Economic Data Uncertainty - StocksToTrade Sun, 21 Dec 2025 08
- NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value - Yahoo Finance ue, 23 Sep 2025 07
- NovaBay Pharma Establishes $100 Million ATM Equity Program - The Globe and Mail Wed, 21 Jan 2026 08
- Market Movers | Winners: NDLS, RXT, SNSE | Losers: SSKN, NAK, OLB - Trefis hu, 19 Feb 2026 04
- Novabay Pharmaceuticals stock hits 52-week high at 11.49 USD - Investing.com Fri, 09 Jan 2026 08
- NovaBay stock more than doubles on thin float — what to watch for NBY when markets reopen - TechStock² Sun, 11 Jan 2026 08
- Massive warrant deals and share increase at NovaBay (NYSE: NBY) head to vote - Stock Titan Mon, 09 Feb 2026 08
- Why Is NovaBay Pharma Stock (NBY) Up Today? - TipRanks Wed, 27 Aug 2025 07
- Assessing NovaBay Pharmaceuticals’ (NBY) Valuation After A Sharp Short Term Share Price Surge - Yahoo Finance Sun, 11 Jan 2026 08
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 6388000 | — | — | LAZAR DAVID ELLIOT | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-21 00:00:00 | D | nan |
| 1 | 6388000 | — | Conversion of Exercise of derivative security at price 99.08 per share. | LAZAR DAVID ELLIOT | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-21 00:00:00 | D | 632923040.0 |
| 2 | 56806080 | — | — | R01 FUND L.P. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-21 00:00:00 | I | nan |
| 3 | 56806080 | — | — | KAZLEY MICHAEL JOHN | Chief Executive Officer | — | 2025-10-21 00:00:00 | I | nan |
| 4 | 56806080 | — | — | FRAMEWORK VENTURES IV L.P. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-21 00:00:00 | I | nan |
| 5 | 28731 | — | Purchase at price 0.46 - 0.58 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-04-08 00:00:00 | D | 15967.0 |
| 6 | 123365 | — | Purchase at price 0.58 - 0.62 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-04-01 00:00:00 | I | 74519.0 |
| 7 | 49927 | — | Purchase at price 0.60 - 0.63 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-03-25 00:00:00 | I | 30718.0 |
| 8 | 64175 | — | Purchase at price 0.58 - 0.64 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-03-18 00:00:00 | I | 39503.0 |
| 9 | 48930 | — | Purchase at price 0.55 - 0.62 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-03-07 00:00:00 | I | 29858.0 |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -5.14M | -4.41M | -4.54M | -13.36M |
| TotalUnusualItems | -782.00K | 312.00K | -2.65M | 4.62M |
| TotalUnusualItemsExcludingGoodwill | -782.00K | 312.00K | -2.65M | 4.62M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -7.21M | -6.14M | -10.61M | -5.82M |
| ReconciledDepreciation | 381.00K | 356.00K | 483.00K | 119.00K |
| ReconciledCostOfRevenue | 3.30M | 4.37M | 6.62M | 3.69M |
| EBITDA | -5.92M | -4.09M | -7.20M | -8.74M |
| EBIT | -6.31M | -4.45M | -7.68M | -8.86M |
| NetInterestIncome | -904.00K | -1.69M | ||
| InterestExpense | 904.00K | 1.69M | ||
| NormalizedIncome | -6.43M | -6.46M | -7.96M | -10.44M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -7.22M | -9.64M | -10.61M | -5.82M |
| TotalExpenses | 14.76M | 14.56M | 22.08M | 19.07M |
| TotalOperatingIncomeAsReported | -5.84M | -4.10M | -14.42M | -8.86M |
| DilutedAverageShares | 3.40M | 120.00K | 46.00K | 35.63K |
| BasicAverageShares | 3.40M | 120.00K | 46.00K | 35.63K |
| DilutedEPS | -2.53 | -139.14 | -353.50 | -184.10 |
| BasicEPS | -2.53 | -139.14 | -353.50 | -184.10 |
| DilutedNIAvailtoComStockholders | -8.61M | -16.70M | -16.27M | -6.56M |
| NetIncomeCommonStockholders | -8.61M | -16.70M | -16.27M | -6.56M |
| OtherunderPreferredStockDividend | 1.39M | 7.06M | 5.66M | 0.00 |
| PreferredStockDividends | 735.00K | |||
| NetIncome | -7.22M | -9.64M | -10.61M | -5.82M |
| NetIncomeIncludingNoncontrollingInterests | -7.22M | -9.64M | -10.61M | -5.82M |
| NetIncomeDiscontinuousOperations | -13.00K | -3.50M | ||
| NetIncomeContinuousOperations | -7.21M | -6.14M | -10.61M | -5.82M |
| TaxProvision | 0.00 | |||
| PretaxIncome | -7.21M | -6.14M | -10.61M | -5.82M |
| OtherIncomeExpense | -1.33M | -349.00K | -2.93M | 3.04M |
| OtherNonOperatingIncomeExpenses | -550.00K | -661.00K | -276.00K | -1.58M |
| SpecialIncomeCharges | -878.00K | 0.00 | -6.18M | 0.00 |
| GainOnSaleOfBusiness | -865.00K | 0.00 | ||
| OtherSpecialCharges | 13.00K | |||
| ImpairmentOfCapitalAssets | 2.59M | 6.74M | 0.00 | |
| RestructuringAndMergernAcquisition | 0.00 | -561.00K | 0.00 | |
| GainOnSaleOfSecurity | 96.00K | 312.00K | 3.52M | 4.62M |
| NetNonOperatingInterestIncomeExpense | -904.00K | -1.69M | ||
| InterestExpenseNonOperating | 904.00K | 1.69M | ||
| OperatingIncome | -4.97M | -4.10M | -7.68M | -8.86M |
| OperatingExpense | 11.46M | 10.19M | 15.46M | 15.38M |
| ResearchAndDevelopment | 42.00K | 34.00K | 174.00K | 44.00K |
| SellingGeneralAndAdministration | 11.41M | 10.15M | 15.29M | 15.33M |
| SellingAndMarketingExpense | 4.03M | 4.71M | 7.80M | 8.09M |
| GeneralAndAdministrativeExpense | 7.38M | 5.45M | 7.49M | 7.24M |
| OtherGandA | 7.38M | 5.45M | 7.49M | 7.24M |
| GrossProfit | 6.48M | 6.08M | 7.78M | 6.51M |
| CostOfRevenue | 3.30M | 4.37M | 6.62M | 3.69M |
| TotalRevenue | 9.78M | 10.46M | 14.40M | 10.20M |
| OperatingRevenue | 9.75M | 10.46M | 14.37M | 10.18M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 4.89M | 320.86K | 58.14K | 38.99K |
| ShareIssued | 4.89M | 320.86K | 58.14K | 38.99K |
| NetDebt | 135.00K | |||
| TotalDebt | 1.67M | 2.61M | 2.04M | 551.00K |
| TangibleBookValue | -135.00K | 1.36M | 4.95M | -237.00K |
| InvestedCapital | 430.00K | 2.50M | 7.58M | 9.60M |
| WorkingCapital | -908.00K | 2.88M | 7.08M | 9.73M |
| NetTangibleAssets | -129.00K | 3.31M | 7.93M | 443.00K |
| CapitalLeaseObligations | 1.11M | 1.48M | 2.04M | 446.00K |
| CommonStockEquity | -135.00K | 1.36M | 7.58M | 9.49M |
| PreferredStockEquity | 6.00K | 1.95M | 2.97M | 680.00K |
| TotalCapitalization | -129.00K | 3.31M | 10.55M | 10.17M |
| TotalEquityGrossMinorityInterest | -129.00K | 3.31M | 10.55M | 10.17M |
| StockholdersEquity | -129.00K | 3.31M | 10.55M | 10.17M |
| RetainedEarnings | -183.46M | -174.85M | -158.15M | -141.89M |
| AdditionalPaidInCapital | 183.27M | 176.21M | 165.71M | 150.90M |
| CapitalStock | 55.00K | 1.95M | 2.99M | 1.16M |
| CommonStock | 49.00K | 3.00K | 20.00K | 478.00K |
| PreferredStock | 6.00K | 1.95M | 2.97M | 680.00K |
| TotalLiabilitiesNetMinorityInterest | 3.55M | 5.72M | 5.84M | 13.81M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 709.00K | 1.44M | 1.59M | 10.37M |
| OtherNonCurrentLiabilities | 334.00K | 561.00K | ||
| DerivativeProductLiabilities | 0.00 | 334.00K | 0.00 | 9.56M |
| LongTermDebtAndCapitalLeaseObligation | 709.00K | 1.11M | 1.59M | 246.00K |
| LongTermCapitalLeaseObligation | 709.00K | 1.11M | 1.59M | 246.00K |
| CurrentLiabilities | 2.84M | 4.28M | 4.26M | 3.44M |
| OtherCurrentLiabilities | 698.00K | |||
| CurrentDeferredLiabilities | 488.00K | 946.00K | 1.81M | 1.29M |
| CurrentDeferredRevenue | 488.00K | 946.00K | 1.81M | 1.29M |
| CurrentDebtAndCapitalLeaseObligation | 963.00K | 1.50M | 453.00K | 305.00K |
| CurrentCapitalLeaseObligation | 398.00K | 368.00K | 453.00K | 200.00K |
| CurrentDebt | 565.00K | 1.14M | 105.00K | |
| OtherCurrentBorrowings | 565.00K | 1.14M | ||
| LineOfCredit | 0.00 | 105.00K | ||
| PayablesAndAccruedExpenses | 1.39M | 1.13M | 2.00M | 1.85M |
| CurrentAccruedExpenses | 769.00K | 223.00K | 917.00K | 803.00K |
| Payables | 623.00K | 906.00K | 1.08M | 1.04M |
| AccountsPayable | 623.00K | 906.00K | 1.08M | 1.04M |
| TotalAssets | 3.42M | 9.03M | 16.40M | 23.98M |
| TotalNonCurrentAssets | 1.49M | 1.88M | 5.07M | 10.81M |
| OtherNonCurrentAssets | 480.00K | 497.00K | 489.00K | 476.00K |
| GoodwillAndOtherIntangibleAssets | 0.00 | 2.63M | 9.73M | |
| OtherIntangibleAssets | 2.28M | 5.20M | ||
| Goodwill | 0.00 | 348.00K | 4.53M | |
| NetPPE | 1.01M | 1.38M | 1.95M | 604.00K |
| AccumulatedDepreciation | -689.00K | -673.00K | -622.00K | -641.00K |
| GrossPPE | 1.70M | 2.06M | 2.57M | 1.25M |
| Leases | 152.00K | 152.00K | 152.00K | 79.00K |
| OtherProperties | 1.83M | 114.00K | ||
| MachineryFurnitureEquipment | 590.00K | 608.00K | 589.00K | 641.00K |
| BuildingsAndImprovements | 955.00K | 1.30M | 1.83M | 411.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 1.94M | 7.15M | 11.33M | 13.17M |
| OtherCurrentAssets | 110.00K | 81.00K | 159.00K | 129.00K |
| AssetsHeldForSaleCurrent | 48.00K | 2.79M | ||
| PrepaidAssets | 117.00K | 90.00K | 358.00K | 631.00K |
| Inventory | 765.00K | 501.00K | 3.44M | 3.22M |
| InventoriesAdjustmentsAllowances | -106.00K | -264.00K | -499.00K | -641.00K |
| OtherInventories | -48.00K | -2.35M | ||
| FinishedGoods | 792.00K | 2.17M | 2.66M | 2.68M |
| RawMaterials | 127.00K | 943.00K | 1.27M | 1.18M |
| Receivables | 465.00K | 765.00K | 2.02M | 1.69M |
| OtherReceivables | 76.00K | 85.00K | 43.00K | 18.00K |
| AccountsReceivable | 389.00K | 680.00K | 1.97M | 1.67M |
| AllowanceForDoubtfulAccountsReceivable | -3.00K | -3.00K | -19.00K | 0.00 |
| GrossAccountsReceivable | 392.00K | 683.00K | 1.99M | 1.67M |
| CashCashEquivalentsAndShortTermInvestments | 430.00K | 2.92M | 5.36M | 7.50M |
| CashAndCashEquivalents | 430.00K | 2.92M | 5.36M | 7.50M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.19M | -4.28M | -6.77M | -9.24M |
| RepaymentOfDebt | -1.99M | -1.47M | -105.00K | 0.00 |
| IssuanceOfDebt | 500.00K | 3.00M | 0.00 | 105.00K |
| IssuanceOfCapitalStock | 2.86M | 0.00 | 3.04M | 16.68M |
| CapitalExpenditure | -6.00K | -19.00K | -112.00K | -52.00K |
| InterestPaidSupplementalData | 147.00K | 189.00K | 17.00K | 0.00 |
| IncomeTaxPaidSupplementalData | 359.00K | 24.00K | 21.00K | |
| EndCashPosition | 907.00K | 3.40M | 5.85M | 7.98M |
| OtherCashAdjustmentOutsideChangeinCash | 126.00K | 297.00K | ||
| BeginningCashPosition | 3.61M | 5.85M | 7.98M | 12.43M |
| ChangesInCash | -2.83M | -2.74M | -2.13M | -4.45M |
| CashFlowFromDiscontinuedOperation | -206.00K | -373.00K | ||
| FinancingCashFlow | 1.50M | 1.91M | 4.63M | 16.79M |
| CashFlowFromContinuingFinancingActivities | 1.50M | 1.91M | 4.63M | 16.79M |
| NetOtherFinancingCharges | -115.00K | -181.00K | ||
| ProceedsFromStockOptionExercised | 247.00K | 565.00K | 1.70M | 0.00 |
| NetPreferredStockIssuance | 0.00 | 3.04M | 14.91M | |
| PreferredStockIssuance | 0.00 | 3.04M | 14.91M | |
| NetCommonStockIssuance | 2.86M | 0.00 | 0.00 | 1.78M |
| CommonStockIssuance | 2.86M | 0.00 | 0.00 | 1.78M |
| NetIssuancePaymentsOfDebt | -1.49M | 1.53M | -105.00K | 105.00K |
| NetShortTermDebtIssuance | -1.49M | 1.53M | -105.00K | 105.00K |
| ShortTermDebtPayments | -1.99M | -1.47M | -105.00K | |
| ShortTermDebtIssuance | 500.00K | 3.00M | 0.00 | 105.00K |
| NetLongTermDebtIssuance | 0.00 | |||
| LongTermDebtPayments | 0.00 | |||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | 1.06M | -19.00K | -112.00K | -12.04M |
| CashFlowFromContinuingInvestingActivities | 1.06M | -19.00K | -112.00K | -12.04M |
| NetBusinessPurchaseAndSale | 1.07M | 0.00 | 0.00 | -11.99M |
| SaleOfBusiness | 1.07M | 0.00 | ||
| PurchaseOfBusiness | 0.00 | -11.99M | ||
| NetPPEPurchaseAndSale | -6.00K | -19.00K | -112.00K | -52.00K |
| PurchaseOfPPE | -6.00K | -19.00K | -112.00K | -52.00K |
| OperatingCashFlow | -5.18M | -4.26M | -6.65M | -9.19M |
| CashFlowFromContinuingOperatingActivities | -5.18M | -4.26M | -6.65M | -9.19M |
| ChangeInWorkingCapital | -595.00K | -433.00K | 533.00K | -38.00K |
| ChangeInOtherCurrentLiabilities | -369.00K | -319.00K | 1.59M | -57.00K |
| ChangeInOtherCurrentAssets | -2.00K | -6.00K | -1.43M | 25.00K |
| ChangeInPayablesAndAccruedExpense | -195.00K | -1.13M | 667.00K | -163.00K |
| ChangeInPayable | -195.00K | -1.13M | 667.00K | -163.00K |
| ChangeInAccountPayable | -195.00K | -1.13M | 667.00K | -163.00K |
| ChangeInPrepaidAssets | -48.00K | 11.00K | 218.00K | -52.00K |
| ChangeInInventory | -272.00K | 162.00K | -217.00K | -243.00K |
| ChangeInReceivables | 291.00K | 846.00K | -305.00K | 452.00K |
| ChangesInAccountReceivables | 291.00K | 846.00K | -305.00K | 452.00K |
| OtherNonCashItems | 1.13M | 1.29M | -561.00K | |
| StockBasedCompensation | 148.00K | 291.00K | 220.00K | 1.15M |
| AssetImpairmentCharge | 2.60M | 6.80M | 0.00 | |
| DepreciationAmortizationDepletion | 381.00K | 356.00K | 483.00K | 119.00K |
| DepreciationAndAmortization | 381.00K | 356.00K | 483.00K | 119.00K |
| AmortizationCashFlow | 152.00K | 363.00K | 60.00K | |
| AmortizationOfIntangibles | 152.00K | 363.00K | 60.00K | |
| Depreciation | 381.00K | 356.00K | 120.00K | 59.00K |
| OperatingGainsLosses | 851.00K | -20.00K | -3.52M | -4.60M |
| GainLossOnInvestmentSecurities | -27.00K | -20.00K | -3.52M | -4.60M |
| GainLossOnSaleOfPPE | 0.00 | |||
| GainLossOnSaleOfBusiness | 865.00K | 0.00 | ||
| NetIncomeFromContinuingOperations | -7.10M | -5.74M | -10.61M | -5.82M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NBY
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|